CVS's app is designed as a one-stop shop for customers to do everything from manage prescriptions to opening locked display ...

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Edward Jones has upgraded CVS Health (CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. Read more here.

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...

CVS Health (CVS) closed at $56.82 in the latest trading session, marking a -0.14% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.53% for the day. Elsewhere, ...

CVS just announced that it’s giving customers the ability to unlock the products they want with a new app, but it’s so ...

To bridge this gap, CVS is (slowly!) rolling out a new feature that would grant shoppers access to caged merchandise. But ...

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.